Breast Cancer (NBCC Workshop Report)
Phase III Antibody Trial Results Look Promising
Published in Women's Health Weekly, November 3rd, 1997
Speaking at a September 30, 1997 media workshop in New York City, New York, organized by the National Breast Cancer Coalition (NBCC), Dennis Slamon, M.D., director of the Revlon-UCLA Cancer Research Program, said that preliminary results from a Phase III clinical trial of an antibody treatment designed to block a growth factor produced by the proto-oncogene HER2/neu (also called erb2) look promising.
Dr. Slamon's research has shown that approximately 30 percent of breast tumors (and 20 percent of ovarian tumors) have multiple copies of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- AIDS/HIV (Clinical Trials)
Researchers To Modify AIDS Drug Study In Africa - AIDS/HIV (Clinical Trials)
Vanderbilt Hopes To Reduce Vertical Transmission - Bacterial Vaginosis
Tampon Testing For STDs - Breast Cancer (Funding)
$1.5 Million Invested for Research Into New Detection Technologies - Breast Cancer (NBCC Workshop Report)
Study Confirms Reduced Risk in Women Who Exercise - Breast Implants
FDA Refuses To Change Regulations on Silicone Breast Implants - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
